Table 2 The VIF table.

From: In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeutics

SpMax3_Bhv

SIC1

SpMin3_Bhi

1

0.877314

0.687557

0.877314

1

0.59803

0.687557

0.59803

1

5.290694

-3.83924

-1.34167

-3.83924

4.342735

0.042609

-1.34167

0.042609

1.896996

Back to article page